The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
Original Source:
https://www.foxnews.com/health/new-option-available-alzheimers-patients-fda-approves-expanded-drug-use
